Please use this identifier to cite or link to this item:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/16215
Full metadata record
???org.dspace.app.webui.jsptag.ItemTag.dcfield??? | Value | Language |
---|---|---|
dc.contributor.advisor | 蔡錦華 | |
dc.contributor.author | Shih-Ting Wang | en |
dc.contributor.author | 王詩婷 | zh_TW |
dc.date.accessioned | 2021-06-07T18:05:24Z | - |
dc.date.copyright | 2012-09-19 | |
dc.date.issued | 2012 | |
dc.date.submitted | 2012-07-25 | |
dc.identifier.citation | Adamson, A. L., Darr, D., Holley-Guthrie, E., Johnson, R. A., Mauser, A., Swenson, J. & Kenney, S. (2000). Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases. Journal of virology 74, 1224-1233.
Adamson, A. L. & Kenney, S. (1999). The Epstein-Barr virus BZLF1 protein interacts physically and functionally with the histone acetylase CREB-binding protein. Journal of virology 73, 6551-6558. Avruch, J. (2007). MAP kinase pathways: the first twenty years. Biochimica et biophysica acta 1773, 1150-1160. Baer, R., Bankier, A. T., Biggin, M. D., Deininger, P. L., Farrell, P. J., Gibson, T. J., Hatfull, G., Hudson, G. S., Satchwell, S. C., Seguin, C. & et al. (1984). DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310, 207-211. Baik, S. Y., Yun, H. S., Lee, H. J., Lee, M. H., Jung, S. E., Kim, J. W., Jeon, J. P., Shin, Y. K., Rhee, H. S., Kimm, K. C. & Han, B. G. (2007). Identification of stathmin 1 expression induced by Epstein-Barr virus in human B lymphocytes. Cell proliferation 40, 268-281. Bermudez, O., Pages, G. & Gimond, C. (2010). The dual-specificity MAP kinase phosphatases: critical roles in development and cancer. American journal of physiology Cell physiology 299, C189-202. Bogoyevitch, M. A. & Court, N. W. (2004). Counting on mitogen-activated protein kinases--ERKs 3, 4, 5, 6, 7 and 8. Cellular signalling 16, 1345-1354. Borza, C. M. & Hutt-Fletcher, L. M. (2002). Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nature medicine 8, 594-599. Boutros, T., Chevet, E. & Metrakos, P. (2008). Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase regulation: roles in cell growth, death, and cancer. Pharmacological reviews 60, 261-310. Burkitt, D. (1958). A sarcoma involving the jaws in African children. The British journal of surgery 46, 218-223. Carter, K. L., Cahir-McFarland, E. & Kieff, E. (2002). Epstein-barr virus-induced changes in B-lymphocyte gene expression. Journal of virology 76, 10427-10436. Caunt, C. J., Rivers, C. A., Conway-Campbell, B. L., Norman, M. R. & McArdle, C. A. (2008). Epidermal growth factor receptor and protein kinase C signaling to ERK2: spatiotemporal regulation of ERK2 by dual specificity phosphatases. The Journal of biological chemistry 283, 6241-6252. Cayrol, C. & Flemington, E. K. (1995). Identification of cellular target genes of the Epstein-Barr virus transactivator Zta: activation of transforming growth factor beta igh3 (TGF-beta igh3) and TGF-beta 1. Journal of virology 69, 4206-4212. Chang, Y., Lee, H. H., Chang, S. S., Hsu, T. Y., Wang, P. W., Chang, Y. S., Takada, K. & Tsai, C. H. (2004). Induction of Epstein-Barr virus latent membrane protein 1 by a lytic transactivator Rta. Journal of virology 78, 13028-13036. Chang, Y., Lee, H. H., Chen, Y. T., Lu, J., Wu, S. Y., Chen, C. W., Takada, K. & Tsai, C. H. (2006). Induction of the early growth response 1 gene by Epstein-Barr virus lytic transactivator Zta. Journal of virology 80, 7748-7755. Chang, Y., Tung, C. H., Huang, Y. T., Lu, J., Chen, J. Y. & Tsai, C. H. (1999). Requirement for cell-to-cell contact in Epstein-Barr virus infection of nasopharyngeal carcinoma cells and keratinocytes. Journal of virology 73, 8857-8866. Chang, Y. N., Dong, D. L., Hayward, G. S. & Hayward, S. D. (1990). The Epstein-Barr virus Zta transactivator: a member of the bZIP family with unique DNA-binding specificity and a dimerization domain that lacks the characteristic heptad leucine zipper motif. Journal of virology 64, 3358-3369. Charles, C. H., Abler, A. S. & Lau, L. F. (1992). cDNA sequence of a growth factor-inducible immediate early gene and characterization of its encoded protein. Oncogene 7, 187-190. Chen, C., Li, D. & Guo, N. (2009). Regulation of cellular and viral protein expression by the Epstein-Barr virus transcriptional regulator Zta: implications for therapy of EBV associated tumors. Cancer biology & therapy 8, 987-995. Chen, S. Y., Lu, J., Shih, Y. C. & Tsai, C. H. (2002). Epstein-Barr virus latent membrane protein 2A regulates c-Jun protein through extracellular signal-regulated kinase. Journal of virology 76, 9556-9561. Chen, X., Liang, S., Zheng, W., Liao, Z., Shang, T. & Ma, W. (2008). Meta-analysis of nasopharyngeal carcinoma microarray data explores mechanism of EBV-regulated neoplastic transformation. BMC genomics 9, 322. Chen, Y. R., Shrivastava, A. & Tan, T. H. (2001). Down-regulation of the c-Jun N-terminal kinase (JNK) phosphatase M3/6 and activation of JNK by hydrogen peroxide and pyrrolidine dithiocarbamate. Oncogene 20, 367-374. Cotsiki, M., Oehrl, W., Samiotaki, M., Theodosiou, A. & Panayotou, G. (2012). Phosphorylation of the M3/6 dual-specificity phosphatase enhances the activation of JNK by arsenite. Cellular signalling 24, 664-676. Countryman, J. & Miller, G. (1985). Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. Proceedings of the National Academy of Sciences of the United States of America 82, 4085-4089. Derijard, B., Hibi, M., Wu, I. H., Barrett, T., Su, B., Deng, T., Karin, M. & Davis, R. J. (1994). JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76, 1025-1037. Dickinson, R. J. & Keyse, S. M. (2006). Diverse physiological functions for dual-specificity MAP kinase phosphatases. Journal of cell science 119, 4607-4615. Diehl, V., Kirchner, H. H., Schaadt, M., Fonatsch, C., Stein, H., Gerdes, J. & Boie, C. (1981). Hodgkin's disease: establishment and characterization of four in vitro cell lies. Journal of cancer research and clinical oncology 101, 111-124. Dolyniuk, M., Pritchett, R. & Kieff, E. (1976a). Proteins of Epstein-Barr virus. I. Analysis of the polypeptides of purified enveloped Epstein-Barr virus. Journal of virology 17, 935-949. Dolyniuk, M., Wolff, E. & Kieff, E. (1976b). Proteins of Epstein-Barr Virus. II. Electrophoretic analysis of the polypeptides of the nucleocapsid and the glucosamine- and polysaccharide-containing components of enveloped virus. Journal of virology 18, 289-297. Eliopoulos, A. G., Gallagher, N. J., Blake, S. M., Dawson, C. W. & Young, L. S. (1999). Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production. The Journal of biological chemistry 274, 16085-16096. Eliopoulos, A. G., Stack, M., Dawson, C. W., Kaye, K. M., Hodgkin, L., Sihota, S., Rowe, M. & Young, L. S. (1997). Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors. Oncogene 14, 2899-2916. Epstein, M. A., Achong, B. G. & Barr, Y. M. (1964). Virus Particles in Cultured Lymphoblasts from Burkitt's Lymphoma. Lancet 1, 702-703. Epstein, M. A. & Barr, Y. M. (1964). Cultivation in Vitro of Human Lymphoblasts from Burkitt's Malignant Lymphoma. Lancet 1, 252-253. Farooq, A., Plotnikova, O., Chaturvedi, G., Yan, S., Zeng, L., Zhang, Q. & Zhou, M. M. (2003). Solution structure of the MAPK phosphatase PAC-1 catalytic domain. Insights into substrate-induced enzymatic activation of MKP. Structure 11, 155-164. Feederle, R., Kost, M., Baumann, M., Janz, A., Drouet, E., Hammerschmidt, W. & Delecluse, H. J. (2000). The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. The EMBO journal 19, 3080-3089. Fenton, M. & Sinclair, A. J. (1999). Divergent requirements for the MAPK(ERK) signal transduction pathway during initial virus infection of quiescent primary B cells and disruption of Epstein-Barr virus latency by phorbol esters. Journal of virology 73, 8913-8916. Fields, B. N., Knipe, D. M. & Howley, P. M. (2007). Fields' virology. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. Fingeroth, J. D., Weis, J. J., Tedder, T. F., Strominger, J. L., Biro, P. A. & Fearon, D. T. (1984). Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proceedings of the National Academy of Sciences of the United States of America 81, 4510-4514. Fixman, E. D., Hayward, G. S. & Hayward, S. D. (1992). trans-acting requirements for replication of Epstein-Barr virus ori-Lyt. Journal of virology 66, 5030-5039. Givant-Horwitz, V., Davidson, B., Goderstad, J. M., Nesland, J. M., Trope, C. G. & Reich, R. (2004). The PAC-1 dual specificity phosphatase predicts poor outcome in serous ovarian carcinoma. Gynecologic oncology 93, 517-523. Given, D. & Kieff, E. (1979). DNA of Epstein-Barr virus. VI. Mapping of the internal tandem reiteration. Journal of virology 31, 315-324. Greenspan, J. S., Greenspan, D., Lennette, E. T., Abrams, D. I., Conant, M. A., Petersen, V. & Freese, U. K. (1985). Replication of Epstein-Barr virus within the epithelial cells of oral 'hairy' leukoplakia, an AIDS-associated lesion. The New England journal of medicine 313, 1564-1571. Gregory, C. D., Dive, C., Henderson, S., Smith, C. A., Williams, G. T., Gordon, J. & Rickinson, A. B. (1991). Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature 349, 612-614. Guan, K. L., Broyles, S. S. & Dixon, J. E. (1991). A Tyr/Ser protein phosphatase encoded by vaccinia virus. Nature 350, 359-362. Han, J., Lee, J. D., Bibbs, L. & Ulevitch, R. J. (1994). A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265, 808-811. Hardwick, J. M., Lieberman, P. M. & Hayward, S. D. (1988). A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen. Journal of virology 62, 2274-2284. Henle, G. & Henle, W. (1966). Immunofluorescence in cells derived from Burkitt's lymphoma. Journal of bacteriology 91, 1248-1256. Henle, G., Henle, W. & Diehl, V. (1968). Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis. Proceedings of the National Academy of Sciences of the United States of America 59, 94-101. Hennessy, K., Fennewald, S., Hummel, M., Cole, T. & Kieff, E. (1984). A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection. Proceedings of the National Academy of Sciences of the United States of America 81, 7207-7211. Hoshi, M., Nishida, E. & Sakai, H. (1988). Activation of a Ca2+-inhibitable protein kinase that phosphorylates microtubule-associated protein 2 in vitro by growth factors, phorbol esters, and serum in quiescent cultured human fibroblasts. The Journal of biological chemistry 263, 5396-5401. Hsu, T. Y., Chang, Y., Wang, P. W., Liu, M. Y., Chen, M. R., Chen, J. Y. & Tsai, C. H. (2005). Reactivation of Epstein-Barr virus can be triggered by an Rta protein mutated at the nuclear localization signal. The Journal of general virology 86, 317-322. Imai, S., Nishikawa, J. & Takada, K. (1998). Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. Journal of virology 72, 4371-4378. Jeffrey, K. L., Brummer, T., Rolph, M. S., Liu, S. M., Callejas, N. A., Grumont, R. J., Gillieron, C., Mackay, F., Grey, S., Camps, M., Rommel, C., Gerondakis, S. D. & Mackay, C. R. (2006). Positive regulation of immune cell function and inflammatory responses by phosphatase PAC-1. Nature immunology 7, 274-283. Johansson, B., Klein, G., Henle, W. & Henle, G. (1970). Epstein-Barr virus (EBV)-associated antibody patterns in malignant lymphoma and leukemia. I. Hodgkin's disease. International journal of cancer Journal international du cancer 6, 450-462. Jones, J. F., Shurin, S., Abramowsky, C., Tubbs, R. R., Sciotto, C. G., Wahl, R., Sands, J., Gottman, D., Katz, B. Z. & Sklar, J. (1988). T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. The New England journal of medicine 318, 733-741. Joseph, A. M., Babcock, G. J. & Thorley-Lawson, D. A. (2000). Cells expressing the Epstein-Barr virus growth program are present in and restricted to the naive B-cell subset of healthy tonsils. Journal of virology 74, 9964-9971. Kaykas, A., Worringer, K. & Sugden, B. (2002). LMP-1's transmembrane domains encode multiple functions required for LMP-1's efficient signaling. Journal of virology 76, 11551-11560. Keyse, S. M. (2008). Dual-specificity MAP kinase phosphatases (MKPs) and cancer. Cancer metastasis reviews 27, 253-261. Keyse, S. M. & Emslie, E. A. (1992). Oxidative stress and heat shock induce a human gene encoding a protein-tyrosine phosphatase. Nature 359, 644-647. Kikuta, H., Taguchi, Y., Tomizawa, K., Kojima, K., Kawamura, N., Ishizaka, A., Sakiyama, Y., Matsumoto, S., Imai, S., Kinoshita, T. & et al. (1988). Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature 333, 455-457. Kim, S. C., Hahn, J. S., Min, Y. H., Yoo, N. C., Ko, Y. W. & Lee, W. J. (1999). Constitutive activation of extracellular signal-regulated kinase in human acute leukemias: combined role of activation of MEK, hyperexpression of extracellular signal-regulated kinase, and downregulation of a phosphatase, PAC1. Blood 93, 3893-3899. Klein, G., Giovanella, B., Westman, A., Stehlin, J. S. & Mumford, D. (1975). An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection. Intervirology 5, 319-334. Kyriakis, J. M., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E. A., Ahmad, M. F., Avruch, J. & Woodgett, J. R. (1994). The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369, 156-160. Labrecque, L. G., Barnes, D. M., Fentiman, I. S. & Griffin, B. E. (1995). Epstein-Barr virus in epithelial cell tumors: a breast cancer study. Cancer research 55, 39-45. Laherty, C. D., Hu, H. M., Opipari, A. W., Wang, F. & Dixit, V. M. (1992). The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B. The Journal of biological chemistry 267, 24157-24160. Li, D., Qian, L., Chen, C., Shi, M., Yu, M., Hu, M., Song, L., Shen, B. & Guo, N. (2009a). Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation. J Immunol 182, 1799-1809. Li, H. P. & Chang, Y. S. (2003). Epstein-Barr virus latent membrane protein 1: structure and functions. Journal of biomedical science 10, 490-504. Li, Z., Hassan, M. Q., Jafferji, M., Aqeilan, R. I., Garzon, R., Croce, C. M., van Wijnen, A. J., Stein, J. L., Stein, G. S. & Lian, J. B. (2009b). Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation. The Journal of biological chemistry 284, 15676-15684. Lieberman, P. M., Hardwick, J. M., Sample, J., Hayward, G. S. & Hayward, S. D. (1990). The zta transactivator involved in induction of lytic cycle gene expression in Epstein-Barr virus-infected lymphocytes binds to both AP-1 and ZRE sites in target promoter and enhancer regions. Journal of virology 64, 1143-1155. Lin, Z., Yin, Q. & Flemington, E. (2004). Identification of a negative regulatory element in the Epstein-Barr virus Zta transactivation domain that is regulated by the cell cycle control factors c-Myc and E2F1. Journal of virology 78, 11962-11971. Liu, Y., Shepherd, E. G. & Nelin, L. D. (2007). MAPK phosphatases--regulating the immune response. Nature reviews Immunology 7, 202-212. Luka, J., Kallin, B. & Klein, G. (1979). Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology 94, 228-231. Macsween, K. F. & Crawford, D. H. (2003). Epstein-Barr virus-recent advances. The Lancet infectious diseases 3, 131-140. Mahot, S., Sergeant, A., Drouet, E. & Gruffat, H. (2003). A novel function for the Epstein-Barr virus transcription factor EB1/Zta: induction of transcription of the hIL-10 gene. The Journal of general virology 84, 965-974. Martell, K. J., Seasholtz, A. F., Kwak, S. P., Clemens, K. K. & Dixon, J. E. (1995). hVH-5: a protein tyrosine phosphatase abundant in brain that inactivates mitogen-activated protein kinase. Journal of neurochemistry 65, 1823-1833. Menezes, J., Leibold, W., Klein, G. & Clements, G. (1975). Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma. Biomedicine / [publiee pour l'AAICIG] 22, 276-284. Middeldorp, J. M. & Pegtel, D. M. (2008). Multiple roles of LMP1 in Epstein-Barr virus induced immune escape. Seminars in cancer biology 18, 388-396. Miller, G., Himmelfarb, H., Heston, L., Countryman, J., Gradoville, L., Baumann, R., Chi, T. & Carey, M. (1993). Comparing regions of the Epstein-Barr virus ZEBRA protein which function as transcriptional activating sequences in Saccharomyces cerevisiae and in B cells. Journal of virology 67, 7472-7481. Morris, M. A., Dawson, C. W. & Young, L. S. (2009). Role of the Epstein-Barr virus-encoded latent membrane protein-1, LMP1, in the pathogenesis of nasopharyngeal carcinoma. Future Oncol 5, 811-825. Mosialos, G., Birkenbach, M., Yalamanchili, R., VanArsdale, T., Ware, C. & Kieff, E. (1995). The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80, 389-399. Murono, S., Inoue, H., Tanabe, T., Joab, I., Yoshizaki, T., Furukawa, M. & Pagano, J. S. (2001). Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells. Proceedings of the National Academy of Sciences of the United States of America 98, 6905-6910. Nakagomi, H., Dolcetti, R., Bejarano, M. T., Pisa, P., Kiessling, R. & Masucci, M. G. (1994). The Epstein-Barr virus latent membrane protein-1 (LMP1) induces interleukin-10 production in Burkitt lymphoma lines. International journal of cancer Journal international du cancer 57, 240-244. Nemerow, G. R., Mold, C., Schwend, V. K., Tollefson, V. & Cooper, N. R. (1987). Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d. Journal of virology 61, 1416-1420. Nunes-Xavier, C., Roma-Mateo, C., Rios, P., Tarrega, C., Cejudo-Marin, R., Tabernero, L. & Pulido, R. (2011). Dual-specificity MAP kinase phosphatases as targets of cancer treatment. Anti-cancer agents in medicinal chemistry 11, 109-132. Owens, D. M. & Keyse, S. M. (2007). Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases. Oncogene 26, 3203-3213. Palacios, C., Collins, M. K. & Perkins, G. R. (2001). The JNK phosphatase M3/6 is inhibited by protein-damaging stress. Current biology : CB 11, 1439-1443. Patterson, K. I., Brummer, T., O'Brien, P. M. & Daly, R. J. (2009). Dual-specificity phosphatases: critical regulators with diverse cellular targets. The Biochemical journal 418, 475-489. Peng, M. & Lundgren, E. (1992). Transient expression of the Epstein-Barr virus LMP1 gene in human primary B cells induces cellular activation and DNA synthesis. Oncogene 7, 1775-1782. Petosa, C., Morand, P., Baudin, F., Moulin, M., Artero, J. B. & Muller, C. W. (2006). Structural basis of lytic cycle activation by the Epstein-Barr virus ZEBRA protein. Molecular cell 21, 565-572. Pope, J. H., Horne, M. K. & Scott, W. (1968). Transformation of foetal human keukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus. International journal of cancer Journal international du cancer 3, 857-866. Puls, A., Eliopoulos, A. G., Nobes, C. D., Bridges, T., Young, L. S. & Hall, A. (1999). Activation of the small GTPase Cdc42 by the inflammatory cytokines TNF(alpha) and IL-1, and by the Epstein-Barr virus transforming protein LMP1. Journal of cell science 112 ( Pt 17), 2983-2992. Roberts, M. L. & Cooper, N. R. (1998). Activation of a ras-MAPK-dependent pathway by Epstein-Barr virus latent membrane protein 1 is essential for cellular transformation. Virology 240, 93-99. Rodriguez, A., Jung, E. J., Yin, Q., Cayrol, C. & Flemington, E. K. (2001). Role of c-myc regulation in Zta-mediated induction of the cyclin-dependent kinase inhibitors p21 and p27 and cell growth arrest. Virology 284, 159-169. Rohan, P. J., Davis, P., Moskaluk, C. A., Kearns, M., Krutzsch, H., Siebenlist, U. & Kelly, K. (1993). PAC-1: a mitogen-induced nuclear protein tyrosine phosphatase. Science 259, 1763-1766. Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989). Molecular cloning : a laboratory manual. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory. Satoh, T., Fukuda, M. & Sairenji, T. (2002). Distinct patterns of mitogen-activated protein kinase phosphorylation and Epstein-Barr virus gene expression in Burkitt's lymphoma cell lines versus B lymphoblastoid cell lines. Virus genes 25, 15-21. Shannon-Lowe, C. D., Neuhierl, B., Baldwin, G., Rickinson, A. B. & Delecluse, H. J. (2006). Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells. Proceedings of the National Academy of Sciences of the United States of America 103, 7065-7070. Shibata, D. & Weiss, L. M. (1992). Epstein-Barr virus-associated gastric adenocarcinoma. The American journal of pathology 140, 769-774. Shimizu, N., Tanabe-Tochikura, A., Kuroiwa, Y. & Takada, K. (1994). Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV. Journal of virology 68, 6069-6073. Sixbey, J. W., Vesterinen, E. H., Nedrud, J. G., Raab-Traub, N., Walton, L. A. & Pagano, J. S. (1983). Replication of Epstein-Barr virus in human epithelial cells infected in vitro. Nature 306, 480-483. Speck, S. H., Chatila, T. & Flemington, E. (1997). Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene. Trends in microbiology 5, 399-405. Sturgill, T. W. & Ray, L. B. (1986). Muscle proteins related to microtubule associated protein-2 are substrates for an insulin-stimulatable kinase. Biochemical and biophysical research communications 134, 565-571. Sun, H., Charles, C. H., Lau, L. F. & Tonks, N. K. (1993). MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 75, 487-493. Terrin, L., Dal Col, J., Rampazzo, E., Zancai, P., Pedrotti, M., Ammirabile, G., Bergamin, S., Rizzo, S., Dolcetti, R. & De Rossi, A. (2008). Latent membrane protein 1 of Epstein-Barr virus activates the hTERT promoter and enhances telomerase activity in B lymphocytes. Journal of virology 82, 10175-10187. Theodosiou, A. & Ashworth, A. (2002a). Differential effects of stress stimuli on a JNK-inactivating phosphatase. Oncogene 21, 2387-2397. Theodosiou, A. & Ashworth, A. (2002b). MAP kinase phosphatases. Genome biology 3, REVIEWS3009. Theodosiou, A. M., Rodrigues, N. R., Nesbit, M. A., Ambrose, H. J., Paterson, H., McLellan-Arnold, E., Boyd, Y., Leversha, M. A., Owen, N., Blake, D. J., Ashworth, A. & Davies, K. E. (1996). A member of the MAP kinase phosphatase gene family in mouse containing a complex trinucleotide repeat in the coding region. Human molecular genetics 5, 675-684. Thorley-Lawson, D. A. & Allday, M. J. (2008). The curious case of the tumour virus: 50 years of Burkitt's lymphoma. Nature reviews Microbiology 6, 913-924. Thorley-Lawson, D. A. & Gross, A. (2004). Persistence of the Epstein-Barr virus and the origins of associated lymphomas. The New England journal of medicine 350, 1328-1337. Tsai, C. H., Liu, M. T., Chen, M. R., Lu, J., Yang, H. L., Chen, J. Y. & Yang, C. S. (1997). Characterization of Monoclonal Antibodies to the Zta and DNase Proteins of Epstein-Barr Virus. Journal of biomedical science 4, 69-77. Tsai, C. N., Tsai, C. L., Tse, K. P., Chang, H. Y. & Chang, Y. S. (2002). The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases. Proceedings of the National Academy of Sciences of the United States of America 99, 10084-10089. Tsai, S. C., Lin, S. J., Chen, P. W., Luo, W. Y., Yeh, T. H., Wang, H. W., Chen, C. J. & Tsai, C. H. (2009). EBV Zta protein induces the expression of interleukin-13, promoting the proliferation of EBV-infected B cells and lymphoblastoid cell lines. Blood 114, 109-118. Tsao, S. W., Tramoutanis, G., Dawson, C. W., Lo, A. K. & Huang, D. P. (2002). The significance of LMP1 expression in nasopharyngeal carcinoma. Seminars in cancer biology 12, 473-487. Uchida, J., Yasui, T., Takaoka-Shichijo, Y., Muraoka, M., Kulwichit, W., Raab-Traub, N. & Kikutani, H. (1999). Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses. Science 286, 300-303. Wan, J., Zhang, W., Wu, L., Bai, T., Zhang, M., Lo, K. W., Chui, Y. L., Cui, Y., Tao, Q., Yamamoto, M., Akira, S. & Wu, Z. (2006). BS69, a specific adaptor in the latent membrane protein 1-mediated c-Jun N-terminal kinase pathway. Molecular and cellular biology 26, 448-456. Ward, Y., Gupta, S., Jensen, P., Wartmann, M., Davis, R. J. & Kelly, K. (1994). Control of MAP kinase activation by the mitogen-induced threonine/tyrosine phosphatase PAC1. Nature 367, 651-654. Wu, J., Jin, Y. J., Calaf, G. M., Huang, W. L. & Yin, Y. (2007). PAC1 is a direct transcription target of E2F-1 in apoptotic signaling. Oncogene 26, 6526-6535. Yates, J. L., Warren, N. & Sugden, B. (1985). Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313, 812-815. Yin, Y., Liu, Y. X., Jin, Y. J., Hall, E. J. & Barrett, J. C. (2003). PAC1 phosphatase is a transcription target of p53 in signalling apoptosis and growth suppression. Nature 422, 527-531. Young, L. S., Clark, D., Sixbey, J. W. & Rickinson, A. B. (1986). Epstein-Barr virus receptors on human pharyngeal epithelia. Lancet 1, 240-242. Young, L. S. & Rickinson, A. B. (2004). Epstein-Barr virus: 40 years on. Nature reviews Cancer 4, 757-768. Yuan, J., Cahir-McFarland, E., Zhao, B. & Kieff, E. (2006). Virus and cell RNAs expressed during Epstein-Barr virus replication. Journal of virology 80, 2548-2565. Zhang, Q., Muller, M., Chen, C. H., Zeng, L., Farooq, A. & Zhou, M. M. (2005). New insights into the catalytic activation of the MAPK phosphatase PAC-1 induced by its substrate MAPK ERK2 binding. Journal of molecular biology 354, 777-788. Zheng, Z., Pan, J., Chu, B., Wong, Y. C., Cheung, A. L. & Tsao, S. W. (1999). Downregulation and abnormal expression of E-cadherin and beta-catenin in nasopharyngeal carcinoma: close association with advanced disease stage and lymph node metastasis. Human pathology 30, 458-466. zur Hausen, H., O'Neill, F. J., Freese, U. K. & Hecker, E. (1978). Persisting oncogenic herpesvirus induced by the tumour promotor TPA. Nature 272, 373-375. zur Hausen, H., Schulte-Holthausen, H., Klein, G., Henle, W., Henle, G., Clifford, P. & Santesson, L. (1970). EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 228, 1056-1058. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/16215 | - |
dc.description.abstract | Epstein-Barr virus (EBV) is an oncogenic virus that infects B cells and epithelial cells, and can transform B cells to continuously proliferative lymphoblastoid cell lines (LCLs). Serial lines of evidence indicated that EBV infection is highly correlated with a variety of lymphoproliferative diseases and human carcinomas.
In order to maintain long-term persistence in host cells, EBV can utilize its numerous gene products to activate many signaling pathways, including NF-κB, MAPK, PI3K/Akt, thereby influencing cell division, growth, or cell apoptosis. Previously, we have used cDNA microarray to compare the expression pattern of cellular genes in CD19+ B cells with B95.8 strain EBV-transformed LCLs, and preliminarily found that EBV affects the expression of many dual specificity phosphatases (DUSPs), such as DUSP1, DUSP6 and DUSP8. Given that some DUSPs were known to be the negative regulator in MAPK signaling, therefore, this study will further investigate the interaction between EBV and DUSPs, and also the biological functions of DUSPs in EBV-infected cells. First, we use RT-Q-PCR and RT-PCR to confirm that the expression levels of DUSP1, DUSP2, DUSP6, and DUSP8, are reduced in LCLs, compared to those in CD19+ B cells. Further, we found that EBV lytic transactivator Zta can downregulate the transcription and translation of DUSP2 in Burkitt’s lymphoma cell line, BJAB cells, and in human kidney epithelial cells, HEK293T cells. Meanwhile, we have also discovered that EBV latent membrane protein 1 (LMP1) can inhibit the transcription and translation of DUSP8 in BJAB and another Burkitt’s lymphoma cell line, Ramos cells, Hodgkin lymphoma cell line, L428 cells, and also HEK293T cells. Using luciferase reporter assay, we demonstrated that Zta can regulate the expression of DUSP2 through inhibiting its promoter activity. On the other hand, LMP1, in addition to regulate the promoter activity of DUSP8, can also activate the downstream NF-κB signaling through its C-terminal region, CTAR1 and CTAR2 domain, to inhibit the expression of DUSP8. To investigate the possible roles of DUSPs in EBV-infected B cells, we transduce DUSP2 or DUSP8 to BJAB and LCLs, and found that DUSP8 can downregulate the activation of p38 MAPK and JNK in cells. Surprisingly, we also discovered that the exogenous expression of DUSP8 in BJAB cells diminishes cell growth. Besides, we found that exogenous expression of DUSP2 dramatically changes cell morphology and inhibits cell proliferation in LCLs. However, it seems that DUSP8 does not affect cell proliferation and cell cycle transition in LCLs. This study reveals that EBV gene products, Zta and LMP1, have the ability to regulate the expression of DUSPs in EBV-infected cells, thereby promoting continuous growth of cells to maintain long-term persistence. However, further investigations will be needed to dissect the detail correlation between EBV and DUSPs, and the exact roles of DUSPs in cells. | en |
dc.description.provenance | Made available in DSpace on 2021-06-07T18:05:24Z (GMT). No. of bitstreams: 1 ntu-101-R99445113-1.pdf: 4711617 bytes, checksum: 4111990b86afc6843a69ad7910fc4698 (MD5) Previous issue date: 2012 | en |
dc.description.tableofcontents | 摘要 I
Abstract III 序論 1 研究目的 21 材料與方法 22 結果 43 討論 55 圖 67 表 94 附錄 101 參考文獻 114 | |
dc.language.iso | zh-TW | |
dc.title | 雙特異性去磷酸酶於EB病毒感染細胞中之調控與生物功能 | zh_TW |
dc.title | Regulation and Biological Functions of Dual Specificity Phosphatases in EBV-infected Cells | en |
dc.type | Thesis | |
dc.date.schoolyear | 100-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 李明學,林素珍 | |
dc.subject.keyword | EB病毒,MAPKs,雙特異性去磷酸酶,Zta,LMP1, | zh_TW |
dc.subject.keyword | EBV,MAPKs,DUSPs,Zta,LMP1, | en |
dc.relation.page | 124 | |
dc.rights.note | 未授權 | |
dc.date.accepted | 2012-07-26 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 微生物學研究所 | zh_TW |
Appears in Collections: | 微生物學科所 |
Files in This Item:
File | Size | Format | |
---|---|---|---|
ntu-101-1.pdf Restricted Access | 4.6 MB | Adobe PDF |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.